JP2024516621A5 - - Google Patents
Info
- Publication number
- JP2024516621A5 JP2024516621A5 JP2023565183A JP2023565183A JP2024516621A5 JP 2024516621 A5 JP2024516621 A5 JP 2024516621A5 JP 2023565183 A JP2023565183 A JP 2023565183A JP 2023565183 A JP2023565183 A JP 2023565183A JP 2024516621 A5 JP2024516621 A5 JP 2024516621A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- group
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177692P | 2021-04-21 | 2021-04-21 | |
| US63/177,692 | 2021-04-21 | ||
| PCT/US2022/025614 WO2022226102A1 (en) | 2021-04-21 | 2022-04-20 | Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024516621A JP2024516621A (ja) | 2024-04-16 |
| JP2024516621A5 true JP2024516621A5 (cg-RX-API-DMAC7.html) | 2025-04-08 |
| JP7868811B2 JP7868811B2 (ja) | 2026-06-02 |
Family
ID=83723402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565183A Active JP7868811B2 (ja) | 2021-04-21 | 2022-04-20 | イヌ細胞傷害性tリンパ球関連タンパク質4(ctla-4)に対するイヌモノクローナル抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12110331B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4326324A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7868811B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216131A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022226102A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4326324A4 (en) * | 2021-04-21 | 2026-03-25 | Univ Pennsylvania | Canine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte-Associated Protein 4 (CTLA-4) |
| CN120265660A (zh) * | 2023-04-28 | 2025-07-04 | 宾夕法尼亚大学董事会 | 新型cd19靶向多肽和cd19定向免疫疗法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA314534A (en) * | 1931-08-25 | The United States Gypsum Company | Roof or floor | |
| CA2469833C (en) * | 2001-12-21 | 2008-05-20 | Idexx Laboratories, Inc. | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| WO2009126730A2 (en) * | 2008-04-09 | 2009-10-15 | The Trustees Of The University Of Pennsylvania | Canine single chain fragment variable antibody libraries and uses thereof |
| AU2020312686B2 (en) * | 2019-07-15 | 2026-07-30 | Intervet International B.V. | Caninized antibodies against canine CTLA-4 |
| EP4326324A4 (en) * | 2021-04-21 | 2026-03-25 | Univ Pennsylvania | Canine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte-Associated Protein 4 (CTLA-4) |
-
2022
- 2022-04-20 EP EP22792435.4A patent/EP4326324A4/en active Pending
- 2022-04-20 CA CA3216131A patent/CA3216131A1/en active Pending
- 2022-04-20 WO PCT/US2022/025614 patent/WO2022226102A1/en not_active Ceased
- 2022-04-20 JP JP2023565183A patent/JP7868811B2/ja active Active
-
2023
- 2023-10-20 US US18/491,182 patent/US12110331B2/en active Active
-
2024
- 2024-09-04 US US18/823,863 patent/US20250171541A1/en active Pending